Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Propofol Infusion Syndrome: A Life Threatening Condition Blunted by Continuous Renal Replacement Therapy
Abstract
Jay Pandav and Rasika Hatti
Propofol is a common intensive care unit anesthetic which was approved by FDA in 1989. It possesses sedative, anxiolytic, and anticonvulsant properties. Case reports of Propofol related infusion syndrome (PRIS) started in early 1990s.